Compounded with
Semaglutide
Not verified in the bound record.
Tirzepatide
Not verified in the bound record.
Product evidence does not establish current availability.
Pharmacy evidence record · researched 2026-08-20
Drug Crafters, L.P.
Not verified in the bound record.
Not verified in the bound record.
Product evidence does not establish current availability.
Regulatory compliance
A pathway label describes which federal rules apply — it is not a quality claim.
Section 503A
FDA's compounding-action index labels Drug Crafters a 503A facility, and FDA's referral says it apparently obtained prescriptions for identified individual patients. Section 503A is a statutory pathway, not FDA facility registration.
Section 503B
No exact FDA current-registry row was verified; no categorical 503B-negative claim is made.
Telehealth providers
Clinic Scout links a provider only when an explicit source names the relationship.
Regulatory history
FDA's Form 483, state-referral letter, and compounding-action index were verified. Current Texas board disposition following the referral and actions in other states were not verified.
U.S. Food and Drug Administration · 2018-07-11
FDA recorded two inspection observations concerning aseptic technique and exposed skin. A Form FDA 483 records inspection observations and is not itself a final agency determination.
issuedU.S. Food and Drug Administration · 2019-02-11
FDA referred the matter to the Texas Board of Pharmacy for follow-up and stated that it did not intend to take further action at that time regarding the inspection findings.
referred_to_texas_boardNo Clinic Scout patient reviews are published for this pharmacy. Submissions go through manual moderation before anything appears here.
What this record verifies for you
Each line traces to a citation in the source list below — read the exact captured wording before relying on it.
No superiority claim is made for review volume, ratings, or patient sentiment.
Since 2006, Drug Crafters has been a leader in compounding pharmacy. We provide both sterile and non-sterile patient specific medications to providers, clinics, and patients nationwide.
OBSERVATION 1 Personnel engaged in aseptic processing failed to follow proper aseptic techniques.
After review of the record, FDA does not intend to take further action at this time with regard to the findings of this inspection. Therefore, FDA is referring this matter to the Texas BOP for follow up to ensure appropriate corrective action is taken.
Drug Crafters, L.P., Frisco, TX- 503A Facility
GLP Clinic Scout does not issue a blanket legitimacy verdict. This research record preserves 4 dated first-party or regulator citation(s), 2 regulatory/action record(s), and 7 explicitly unresolved field(s). Review the cited evidence and current license status before making a decision.
Weekly price watch
One useful comparison each week. No spam, no sold lists, and you can unsubscribe anytime.